La Jolla Pharmaceutical Company Accounts Payables 2011-2026 | LJPC

Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.

Main types of accounts payable

Type of liability	Example
To suppliers and contractors	Goods received but not yet paid for
Taxes and fees	VAT, income tax, etc., not paid on time
Salaries	Employee wages not paid
To budgets	Insurance contributions to funds not paid
To founders	Founders provided borrowed funds
To banks	Overdue loan payments
Other	Fines, penalties, forfeits, customer prepayments, etc.

Impact on the company's financial performance

Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios
Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence
Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals)
Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated

Annual Accounts Payables La Jolla Pharmaceutical Company

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.28 M	2.76 M	4.18 M	8.57 M	11.5 M	6.65 M	2.51 M	730 K	834 K	92 K	8 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
11.5 M	8 K	3.64 M

Quarterly Accounts Payables La Jolla Pharmaceutical Company

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	2.12 M	2.79 M	2.28 M	2.31 M	1.85 M	1.1 M	2.76 M	2.76 M	2.76 M	2.76 M	4.18 M	4.18 M	4.18 M	4.18 M	8.57 M	8.57 M	8.57 M	8.57 M	11.5 M	11.5 M	11.5 M	11.5 M	6.65 M	6.65 M	6.65 M	6.65 M	3.05 M	2.51 M	2.51 M	2.51 M	730 K	730 K	730 K	730 K	834 K	834 K	834 K	834 K	92 K	92 K	92 K	92 K	8 K	8 K	8 K	8 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
11.5 M	8 K	3.57 M

Accounts Payables of other stocks in the Biotechnology industry

Issuer	Accounts Payables	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	13.4 M	-	-24.86 %	$ 820 K	USA
I-Mab IMAB	570 M	-	-	$ 866 M	China
Acer Therapeutics ACER	3.81 M	-	2.71 %	$ 14 M	USA
ADMA Biologics ADMA	22.5 M	$ 15.36	-2.17 %	$ 3.66 B	USA
AgeX Therapeutics AGE	1.41 M	-	-10.17 %	$ 12.2 K	USA
Apellis Pharmaceuticals APLS	56.8 M	$ 20.28	0.65 %	$ 2.56 B	USA
Aeglea BioTherapeutics AGLE	677 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	2.91 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	9.03 M	-	-	$ 3.67 B	USA
Akouos AKUS	1.28 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	4.29 M	-	-	$ 2.17 B	USA
AlloVir ALVR	247 K	-	4.14 %	$ 49.1 M	USA
Aptorum Group Limited APM	3.24 M	$ 0.79	-1.15 %	$ 4.31 M	China
Autolus Therapeutics plc AUTL	1.97 M	$ 1.51	1.35 %	$ 385 M	Britain
China SXT Pharmaceuticals SXTC	1.16 M	$ 2.01	-1.36 %	$ 2.86 M	China
Galmed Pharmaceuticals Ltd. GLMD	1.31 M	$ 0.67	7.08 %	$ 624 K	Israel
Adverum Biotechnologies ADVM	1.61 M	-	-	$ 86.2 M	USA
Ampio Pharmaceuticals AMPE	750 K	-	-11.43 %	$ 502 K	USA
Anika Therapeutics ANIK	9.86 M	$ 14.05	-1.44 %	$ 206 M	USA
ANI Pharmaceuticals ANIP	45.7 M	$ 74.36	-1.64 %	$ 1.44 B	USA
Applied Therapeutics APLT	1.74 M	-	-	$ 8.42 M	USA
Aravive ARAV	8.76 M	-	-13.39 %	$ 1.45 M	USA
ARCA biopharma ABIO	3.46 M	-	1052.0 %	$ 415 M	USA
Athersys ATHX	9.16 M	-	3.77 %	$ 22.4 M	USA
AVEO Pharmaceuticals AVEO	2.71 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	65.5 M	$ 162.43	0.6 %	$ 8.08 B	USA
BioCryst Pharmaceuticals BCRX	11.6 M	$ 8.49	-0.18 %	$ 1.75 B	USA
BridgeBio Pharma BBIO	36.2 M	$ 65.66	-0.78 %	$ 12.6 B	USA
Acasti Pharma ACST	601 K	-	4.01 %	$ 150 M	Canada
Brainstorm Cell Therapeutics BCLI	6.08 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	8.11 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	479 M	-	0.49 %	$ 251 B	Cayman-islands
Bellerophon Therapeutics BLPH	1.23 M	-	-74.18 %	$ 955 K	USA
Bellicum Pharmaceuticals BLCM	486 K	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	10.1 M	-	-7.31 %	$ 87 M	USA
BioMarin Pharmaceutical BMRN	32.8 M	$ 61.3	1.21 %	$ 11.8 B	USA
CymaBay Therapeutics CBAY	3.83 M	-	-	$ 3.45 B	USA